Henry L. Nordhoff

Chairman & Chief Executive Officer at Banyan Biomarkers, Inc.

Henry L. Nordhoff

Henry L. Nordhoff

Chairman & Chief Executive Officer at Banyan Biomarkers, Inc.

Overview
Career Highlights

Banyan Biomarkers, Inc.
Gen-Probe, Inc.
Targetech, Inc.

RelSci Relationships

1050

Number of Boards

19

Birthday

1942

Age

79

Relationships
RelSci Relationships are individuals Henry L. Nordhoff likely has professional access to. A relationship does not necessarily indicate a personal connection.

Vice President Revenue Cycle at Trinity Mother Frances Health System

Relationship likelihood: Strong

Founder at Banyan Biomarkers, Inc.

Relationship likelihood: Strong

Director at Banyan Biomarkers, Inc.

Relationship likelihood: Strong

President, Chief Operating Officer & Director at Banyan Biomarkers, Inc.

Relationship likelihood: Strong

Founder at First National Bank

Relationship likelihood: Strong

Founder at Genentech, Inc.

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Executive Officer at NetSapiens, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Executive Director at Institute for Commercialization of Florida Technology

Relationship likelihood: Strong

Founder & Chairman at Shipston Group Ltd.

Relationship likelihood: Strong

Paths to Henry L. Nordhoff
Potential Connections via
Relationship Science
You
Henry L. Nordhoff
Chairman & Chief Executive Officer at Banyan Biomarkers, Inc.
Education
B.A. in International Relations & Political Economy

To educate students, to foster independent & original research, and to share benefits discovered.

Master's Degree in International Business & Finance

Columbia Business School (CBS) is the business school of Columbia University in Manhattan, New York City. It was established in 1916 to provide business training and professional preparation for undergraduate and graduate Columbia University students. It is one of six Ivy League business schools and its admission process is among the most selective of top business schools.

Unknown

Columbia University is one of the world's most important centers of research and at the same time a distinctive and distinguished learning environment for undergraduates and graduate students in many scholarly and professional fields. The University recognizes the importance of its location in New York City and seeks to link its research and teaching to the vast resources of a great metropolis. It seeks to attract a diverse and international faculty and student body, to support research and teaching on global issues, and to create academic relationships with many countries and regions. It expects all areas of the university to advance knowledge and learning at the highest level and to convey the products of its efforts to the world.

Career History
Chairman & Chief Executive Officer
2012 - Current

Banyan Biomarkers, Inc. engages in the commercialization of vitro diagnostic tests for the detection of brain injury and neurological diseases. It develops blood test to accurately and quickly diagnose traumatic brain injury. The company was founded by Nancy Denslow, Ronald L. Hayes, and Kevin Wang in 2002 and is headquartered in San Diego, CA.

Managing Director
Current

Shipston makes investment in the United States, Eastern Europe, Russia, Australia and China. They have extensive experience generating and leading investments through acquisitions, initial public offerings and complex corporate transactions that involve transforming operating units into new public ownership structures.Shipston invests in biotech, clean energy, transportation, healthcare, manufacturing, natural resources and real estate sectors in China.

Chief Executive Officer & President
1994 - 2011

Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA.

Boards & Committees
Member, Advisory Board
Current

GenScript Corp. provides biological research and drug discovery services to pharmaceutical companies. Its products include antibodies, recombinant proteins, protein isolation and analysis, molecular biology reagents, peptides, and cell lines. It offers life sciences research services and preclinical drug development services. The company was founded by Ye Wang, Fang Liang Zhang, and Lu Quan Wang in 2002 and is headquartered in Piscataway, NJ.

Member, Board of Directors
2013 - 2014

Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA.

Chairman
Prior

Founded in 1989 and headquartered in San Diego, AIS provides tailored data center and cloud service solutions to companies that require the best in security, compliance, connectivity, and customer service. AIS manages all aspects of IT infrastructure so that customers can focus on their core business.

Chairman
Prior

CHI was founded in 1993 as an independent 501(c)(6) organization devoted to researching and advocating policy to forward the interests of California’s biomedical community.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$15K - $25K
2019

The Prostate Cancer Foundation (PCF), formerly known as CaP CURE, is the world’s largest philanthropic source of support for prostate cancer research. PCF was founded in 1993 in order to discover better treatments and a cure for prostate cancer. As of 2012, PCF has raised more than $500 million for research and funded more than 1,600 research projects at nearly 200 institutions in 17 countries. In the past 2 years, 5 new drugs that extend the lives of men with metastatic prostate cancer have been approved by the FDA. PCF initiated and supported academic treatment science that fast-forwarded every one of these approvals.

$15K - $25K
2018

The Prostate Cancer Foundation (PCF), formerly known as CaP CURE, is the world’s largest philanthropic source of support for prostate cancer research. PCF was founded in 1993 in order to discover better treatments and a cure for prostate cancer. As of 2012, PCF has raised more than $500 million for research and funded more than 1,600 research projects at nearly 200 institutions in 17 countries. In the past 2 years, 5 new drugs that extend the lives of men with metastatic prostate cancer have been approved by the FDA. PCF initiated and supported academic treatment science that fast-forwarded every one of these approvals.

$250K - $500K
2017

The Prostate Cancer Foundation (PCF), formerly known as CaP CURE, is the world’s largest philanthropic source of support for prostate cancer research. PCF was founded in 1993 in order to discover better treatments and a cure for prostate cancer. As of 2012, PCF has raised more than $500 million for research and funded more than 1,600 research projects at nearly 200 institutions in 17 countries. In the past 2 years, 5 new drugs that extend the lives of men with metastatic prostate cancer have been approved by the FDA. PCF initiated and supported academic treatment science that fast-forwarded every one of these approvals.

Political Donations
$3,000
2014

Representative at Office of the Representative from California's 50th District, Darrell Issa

$1,000
2014

Former Representative from Florida's 3rd Congressional District

$1,500
2013

Representative at Office of the Representative from California's 50th District, Darrell Issa

Transactions
Details Hidden

Banyan Biomarkers, Inc. raised money in a private placement transaction

Details Hidden

Banyan Biomarkers, Inc. raised money in a private placement transaction

Details Hidden

Banyan Biomarkers, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Henry L. Nordhoff. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Henry L. Nordhoff's profile does not indicate a business or promotional relationship of any kind between RelSci and Henry L. Nordhoff.